Supplemental Figure 2

1
F E D C A B Supplemental Figure 2 G L K J I H Supplemental Figure 2. Representative H&E images (20x objective) of the orthotopic xenograft model including (A) viable primary tumor, (B) primary tumor with large area of geographic necrosis, (C) direct extension of tumor into spleen and distant metastatic tumor nodules involving (D) lung, (E) small bowel and (F) diaphragm. Representative sections of normal tissues with no histopathologic abnormalities are shown for mice sacrificed 28-32 days into their treatment course with (G- I) vehicle or (J-L) ICG-001. Sections include (G,J) small bowel, (H,K)

TAGS:

description

Supplemental Figure 2. A. B. C. D. E. F. H. G. I. K. L. J. - PowerPoint PPT Presentation

Transcript of Supplemental Figure 2

Page 1: Supplemental Figure 2

FED

CA B

Supplemental Figure 2

G

LKJ

IH

Supplemental Figure 2. Representative H&E images (20x objective) of the orthotopic xenograft model including (A) viable primary tumor, (B) primary tumor with large area of geographic necrosis, (C) direct extension of tumor into spleen and distant metastatic tumor nodules involving (D) lung, (E) small bowel and (F) diaphragm. Representative sections of normal tissues with no histopathologic abnormalities are shown for mice sacrificed 28-32 days into their treatment course with (G-I) vehicle or (J-L) ICG-001. Sections include (G,J) small bowel, (H,K) colon and (I,J) liver showing no architectural or cytologic abnormalities to suggest cytotoxicity.

Supplemental Figure Legends: Supplemental Figure S1 ...genesdev.cshlp.org/content/suppl/2014/07/11/gad... · Supplemental Figure Legends: Supplemental Figure S1 Vernalization response

Supplemental Figure Legends: Supplemental Figure S1 ...genesdev.cshlp.org/content/suppl/2014/07/11/gad... · Supplemental Figure Legends: Supplemental Figure S1 Vernalization response

Supplemental materials 2 Supplemental Figure 1.Antibody ...dm5migu4zj3pb.cloudfront.net/manuscripts/66000/66824/JCI66824sd.pdf · Supplemental Figure . PRL5 -3 is expressed at higher

Supplemental materials 2 Supplemental Figure 1.Antibody ...dm5migu4zj3pb.cloudfront.net/manuscripts/66000/66824/JCI66824sd.pdf · Supplemental Figure . PRL5 -3 is expressed at higher

Supplemental digital content€¦ · Web viewSupplemental Figure 1. Figure that demonstrates co-cited authors that analyzed by CiteSpace. Supplemental Figure 2. Figure that demonstrates

Supplemental digital content€¦ · Web viewSupplemental Figure 1. Figure that demonstrates co-cited authors that analyzed by CiteSpace. Supplemental Figure 2. Figure that demonstrates

Supplemental Figure 7(1) p u t SUPPLEMENTAL FIGURE 2 A B H3K4me3 loci Title Supplemental Figure 7(1).ai Created Date 20161030123200Z ...

Supplemental Figure 7(1) p u t SUPPLEMENTAL FIGURE 2 A B H3K4me3 loci Title Supplemental Figure 7(1).ai Created Date 20161030123200Z ...

Supplemental data: Supplemental Figure 1. Sequence of ...

Supplemental data: Supplemental Figure 1. Sequence of ...

Supplemental Information - CLST labs websites material_JBO2015.pdfSupplemental figure Figure S1 – S3 2 / 10 Supplemental experimental procedures Conditions for automated tracking

Supplemental Information - CLST labs websites material_JBO2015.pdfSupplemental figure Figure S1 – S3 2 / 10 Supplemental experimental procedures Conditions for automated tracking

Supplemental Figures S1-S8. Supplemental Figure S1.

Supplemental Figures S1-S8. Supplemental Figure S1.

Supplemental Figure 2 - Cancer Discovery · SUPPLEMENTAL FIGURE 2. Title: Supplemental Figure 2 Created Date: 7/29/2016 10:43:37 AM ...

Supplemental Figure 2 - Cancer Discovery · SUPPLEMENTAL FIGURE 2. Title: Supplemental Figure 2 Created Date: 7/29/2016 10:43:37 AM ...

SUPPLEMENTAL FIGURE LEGEND - Weeblydimitrovagen677s09.weebly.com/uploads/1/7/2/1/...1 SUPPLEMENTAL FIGURE LEGEND Supplemental Figure 1. Absence of cardiac developmental abnormalities

SUPPLEMENTAL FIGURE LEGEND - Weeblydimitrovagen677s09.weebly.com/uploads/1/7/2/1/...1 SUPPLEMENTAL FIGURE LEGEND Supplemental Figure 1. Absence of cardiac developmental abnormalities

Figure Legends for Supplemental Figures Supplemental

Figure Legends for Supplemental Figures Supplemental

Supplemental Figure 1 A. · Supplemental Figure 1 A. B. Let-7 target site C. miR-103/107 target site . 2 Supplemental Figure 2 . 3 Supplemental Figure 3 . 4 Supplemental Figure 4

Supplemental Figure 1 A. · Supplemental Figure 1 A. B. Let-7 target site C. miR-103/107 target site . 2 Supplemental Figure 2 . 3 Supplemental Figure 3 . 4 Supplemental Figure 4

SUPPLEMENTAL FIGURE LEGENDS Figure S1. Programmed cell ...genesdev.cshlp.org/.../Supplemental_Figures.pdf · 6.02.2017  · SUPPLEMENTAL FIGURE LEGENDS Figure S1. Programmed cell

SUPPLEMENTAL FIGURE LEGENDS Figure S1. Programmed cell ...genesdev.cshlp.org/.../Supplemental_Figures.pdf · 6.02.2017  · SUPPLEMENTAL FIGURE LEGENDS Figure S1. Programmed cell

1. Supplemental Figure 1 - International Journal of ... · Supplemental Figure 1 2. Supplemental Figure 2 3. Supplemental Figure 3 4. Supplemental Figure 4 5. Supplemental Figure

1. Supplemental Figure 1 - International Journal of ... · Supplemental Figure 1 2. Supplemental Figure 2 3. Supplemental Figure 3 4. Supplemental Figure 4 5. Supplemental Figure

SUPPLEMENTAL INFORMATION 1. Supplemental …misclab.umeoce.maine.edu/documents/BehrenfeldBoss2014...Supplemental Figure 2. Identifying bloom initiation during exponential growth. Using

SUPPLEMENTAL INFORMATION 1. Supplemental …misclab.umeoce.maine.edu/documents/BehrenfeldBoss2014...Supplemental Figure 2. Identifying bloom initiation during exponential growth. Using

Supplemental figure 2.

Supplemental figure 2.

Supplement Supplemental Figures and Supplemental Figure ...

Supplement Supplemental Figures and Supplemental Figure ...

Figure I supplemental

Figure I supplemental

Supplemental Figure 1. 1000 cells/ well DLD-1 ALDH+/CD133+ DLD-1 ALDH- /CD133- Supplemental Figure 2.

Supplemental Figure 1. 1000 cells/ well DLD-1 ALDH+/CD133+ DLD-1 ALDH- /CD133- Supplemental Figure 2.

Supplemental figure 2

Supplemental figure 2

Supplemental Figure 2. Psychophysiological interaction ...

Supplemental Figure 2. Psychophysiological interaction ...